Makary pushes for IRB reforms to catch China's speedy trial starts
马卡里推动机构审查委员会(IRB)改革，以追赶manbetx3.0 快速启动临床试验的步伐

The process by which institutional review boards oversee clinical trials needs reforms that are “big and different” so that the US can keep pace with China, FDA Commissioner Marty Makary said.
美国食品药品监督管理局局长马蒂•马卡里表示，机构审查委员会监督临床试验的流程需要进行“重大且不同以往”的改革，这样美国才能跟上manbetx3.0 的步伐。